TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | -2 | -1 | 48 | -7 | -26 | -18 | -1 |
| P | %wins | 0 | 0 | 100 | 0 | 0 | 0 | 17 | |||
| S | %ret | 1 | 1 | 1 | -2 | -7 | -2 | -36 | -32 | -57 | -23 |
| S | %wins | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/12/14 17:08 | 2/11/14 | EGLT | Egalet Corp | DE | Health | Drug | Pharmaceutical Preparations | Atlas Venture Fund VII L P | MA | T | P.d | 500 | 12.00 | 9 | 42 | 2 | 2,461 | D | 2 | -2 | -1 | 48 | -7 | -26 | -18 | ||||||||
3/31/10 15:05 | 3/29/10 | ABIO | Arca Biopharma, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Atlas Venture Fund VII L P | MA | T | S | -1,058 | 7.56 | 1 | -140 | -9 | 1,338 | D | -61 | 15 | 54 | 76 | 88 | 95 | 103 | 109 | -2 | -7 | -2 | -36 | -32 | -57 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |